Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being de... Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease. Mostra di più
| Periodo † | Var | Var % | Apert. | Max | Min | Med. Vol. Giorn. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.7 | -4.23216444982 | 16.54 | 16.74 | 15.05 | 519696 | 15.62288791 | CS |
| 4 | -0.5 | -3.0599755202 | 16.34 | 17 | 14.05 | 802157 | 15.64008595 | CS |
| 12 | -3.09 | -16.323296355 | 18.93 | 21.58 | 14.05 | 1011351 | 17.7765792 | CS |
| 26 | -6.62 | -29.4746215494 | 22.46 | 27.2 | 14.05 | 1150163 | 20.06222373 | CS |
| 52 | -1.45 | -8.38635049161 | 17.29 | 27.2 | 11.4 | 1161950 | 17.83094133 | CS |
| 156 | -4.29 | -21.3114754098 | 20.13 | 39 | 9.47 | 830058 | 19.65902863 | CS |
| 260 | -5.55 | -25.9467040673 | 21.39 | 39 | 9.47 | 624008 | 19.5041484 | CS |
| Nessuna Discussione Trovata |
| Crea Discussione |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: help@advfn.com
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Caratteristiche principali
Premium
